Advancing Clinical Practice Through Knowledge, Collaboration, and Continuous Improvement At Ionic Global Sdn Bhd (IG), we believe that meaningful progress in healthcare is built through continuous learning, collaboration, and a shared commitment to improving patient outcomes. This partnership with PERDIM represents a step forward in building a healthier, more informed, and resilient society for the future. Following our engagement with PERDIM, we were honoured to further our journey with the Malaysian Doctors of Circumcision Society (MADOCS) during its Continuing Medical Education (CME) session on 26 April 2026. This engagement reflects our ongoing dedication to supporting the medical community through knowledge exchange and evidence-informed initiatives. The session brought together healthcare professionals with a shared objective—to enhance clinical practices through structured discussion, practical insights, and collaborative exploration of improvement opportunities. Representing Ionic Global, our leading wound care consultant, Dr. Clement Apong, together with Director Mr. Baharinshah Hussain and Business Development Advisor Mdm Monica Low, presented on key aspects of circumcision procedures. The discussion focused on gap analysis within current practices, identification of opportunity areas for enhancement, and the role of data management and analysis in supporting more consistent and reliable clinical outcomes. From a clinical perspective, variability in procedural techniques and post-operative care can influence healing progression, patient comfort, and complication rates. As such, the session emphasised the importance of adopting a more structured and standardised framework—one that is guided by data, practitioner experience, and evolving clinical understanding. In supporting this direction, Ionic Global shared perspectives on wound care management, including the importance of maintaining a clean wound environment and managing microbial load—factors widely recognised to influence healing outcomes. Within this context, attention was given to approaches that support effective antimicrobial hygiene while preserving tissue viability, an important balance in modern wound care. This includes the application of Malaysia Homegrown IGTech, Ionic Global’s proprietary technology platform, which underpins the development of the high purity hypochlorous acid (HOCl)-based solutions. HOCl is described in scientific literature as an endogenous antimicrobial agent involved in the body’s innate immune response. At appropriate concentrations, it has been associated with broad-spectrum antimicrobial activity and rapid microbial reduction under controlled conditions, while maintaining a favourable tissue compatibility profile. As the core technology behind Antaviro Wound Care, IGTech is designed to support hygienic wound conditions as part of an integrated and clinically guided care approach—contributing to microbial load management while aligning with principles of tissue preservation and patient comfort. These discussions mark an important step towards the development of a structured “Best Practice” standard procedure framework, aimed at enhancing consistency, safety, and clinical effectiveness in circumcision-related care. The proposed framework will incorporate clinical observations, practitioner feedback, and data-informed insights, forming a practical reference to support healthcare providers in delivering more standardised care. As part of this initiative, a comprehensive proposal is currently being developed and will be submitted to MADOCS in early May 2026, with the intention of supporting further review and potential consideration by the Ministry of Health Malaysia. This reflects a shared aspiration to contribute meaningfully to the evolution of clinical standards at a broader, national level. Beyond the technical discussions, this engagement also highlights the importance of collaboration between industry and healthcare professionals. By creating platforms for open dialogue, shared learning, and continuous improvement, Ionic Global aims to play a supportive role in strengthening clinical practice and advancing patient care. At Ionic Global, we remain humbled by the opportunity to contribute alongside dedicated healthcare practitioners. Through ongoing engagement, responsible innovation, and a commitment to evidence-informed practices, we strive to support a healthcare ecosystem that is more consistent, more informed, and ultimately more patient-centred. As we move forward, we look to these collaborations as building blocks for long-term impact—where knowledge, care, and collaboration come together to shape a better future for healthcare in Malaysia.

Ionic Global at Amazing Clinic Program 2026: Advancing Clinical Practice Through Innovation and Engagement Ionic Global Sdn Bhd was honoured to participate as an exhibitor at the Amazing Clinic Program 2026, organised by Pertubuhan Doktor-Doktor Islam Malaysia (PERDIM), held on 4 March 2026 at Royale Chulan Damansara. The event brought together a wide spectrum of healthcare professionals, clinic owners, and medical practitioners from across Malaysia, providing a meaningful platform for professional exchange, clinical discussions, and knowledge sharing aimed at enhancing patient care and healthcare delivery. Participation in this program reflects Ionic Global’s ongoing commitment to engaging with the medical community and contributing to the advancement of evidence-based clinical practices. As healthcare continues to evolve, such platforms play an essential role in bridging scientific innovation with real-world application, enabling practitioners to stay informed of emerging solutions and approaches in patient management. During the exhibition, Ionic Global showcased Antaviro Wound Care, an advanced antimicrobial wound management solution developed with proprietary IGTECH technology. At the core of Antaviro is stabilised high-purity hypochlorous acid (HOCl), a biomimetic molecule naturally produced by the human immune system and widely recognised for its rapid and broad-spectrum antimicrobial properties. In modern wound care, the role of HOCl extends beyond microbial reduction—it contributes to maintaining a balanced wound environment that supports the natural healing process while minimising tissue irritation. Through IGTECH, Antaviro Wound Care is engineered to deliver a controlled, stable, and high-purity HOCl formulation, addressing common limitations associated with conventional solutions such as instability, reduced efficacy, and inconsistency in performance. This enables reliable antimicrobial action while maintaining excellent biocompatibility, making it suitable for repeated application across a wide range of wound types, including sensitive and infection-prone conditions. By balancing efficacy with tissue safety, Antaviro aligns with the growing clinical demand for solutions that support both infection control and optimal healing outcomes. The event also provided an opportunity for Ionic Global’s team to engage directly with healthcare practitioners, exchanging insights on current clinical challenges and sharing practical applications of Antaviro Wound Care in everyday practice. These interactions are invaluable in ensuring that our solutions remain relevant, effective, and responsive to the needs of front-line medical professionals. Ionic Global extends its sincere appreciation to our Director, En. Baharin, and our Advisor, Mdm Monica, for their leadership, guidance, and continuous support. Their commitment has been instrumental in enabling our team to effectively communicate the clinical value and scientific foundation of our solutions to the healthcare community. As part of our broader mission, Ionic Global remains dedicated to collaborating with healthcare organisations and professionals to promote innovative antimicrobial technologies that enhance patient safety, support effective wound management, and elevate clinical standards. Through continuous engagement, knowledge sharing, and technological advancement, we strive to contribute meaningfully to the future of healthcare in Malaysia and beyond.